ImmuPharma plc (LON:IMM – Get Free Report)’s stock price rose 16.9% during trading on Monday . The stock traded as high as GBX 4.95 ($0.06) and last traded at GBX 4.60 ($0.06). Approximately 15,705,875 shares were traded during mid-day trading, a decline of 19% from the average daily volume of 19,462,320 shares. The stock had previously closed at GBX 3.94 ($0.05).
ImmuPharma Trading Down 20.3 %
The stock has a market cap of £19.57 million, a PE ratio of -470.00 and a beta of 1.53. The firm’s 50-day moving average price is GBX 1.92 and its two-hundred day moving average price is GBX 1.78.
ImmuPharma Company Profile
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Featured Articles
- Five stocks we like better than ImmuPharma
- 5 Top Rated Dividend Stocks to Consider
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Investing In Automotive Stocks
- What Does the Future Hold for Eli Lilly?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
